Hippocampal modulation of sensorimotor processes

Progress in Neurobiology

Volumn 70, Issue 4, 2003, Pages 319-345

  Bast, Tobias ^a,b   Feldon, Joram ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APOMORPHINE; BRETAZENIL; BUSPIRONE; CARBACHOL; CLOZAPINE; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; HALOPERIDOL; KAINIC ACID; LIDOCAINE; MIDAZOLAM; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; NORADRENALIN; ONDANSETRON; PHENCYCLIDINE; PICROTOXIN; QUINPIROLE; RACLOPRIDE; TETRODOTOXIN; TROPISETRON; UNINDEXED DRUG; ZOLPIDEM;

AMNESIA; AMYGDALOID NUCLEUS; ANXIETY DISORDER; AROUSAL; ATTENTION; AVERSION; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN INJURY; BRAIN STEM; COMPARATIVE STUDY; CONVULSION; DEFENSIVE BEHAVIOR; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; HUMAN; HYPERACTIVITY; INTERNEURON; LEARNING; LOCOMOTION; LOW DRUG DOSE; MEMORY; MENTAL DISEASE; MESENCEPHALON; MICRODIALYSIS; MODULATION; NERVE CELL; NEUROPSYCHIATRY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTECTION; PSYCHOSIS; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SEIZURE; SENSORIMOTOR FUNCTION; STARTLE REFLEX; THETA RHYTHM; VENTRAL TEGMENTUM;

EID: 0042280347     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(03)00112-6     Document Type: Review

References (247)

1. Acri J.B., Grunberg N.E., Morse D.E. Effects of nicotine on the acoustic startle reflex amplitude in rats. Psychopharmacology. 104:1991;244-248.
2. Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav. Brain. Sci. 22:1999;425-489.
3. Aggleton J.P., Pearce J.M. Neural systems underlying episodic memory: insights from animal reserach. Phil. Trans. R. Soc. Lond. B. 356:2001;1467-1482.
4. Ahlenius S., Hillegaart V., Thorell G., Magnusson O., Fowler C.J. Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum. Brain. Res. 402:1982;131-138.
5. Alam A.M., Starr M.S. Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology. 35:1996;159-167.
6. Alheid G.F., Heimer L. Theories of basal forebrain organization and the "emotional motor system" Prog. Brain Res. 107:1996;461-484.
7. Altman J., Brunner R.L., Bayer S.A. The hippocampus and behavioral maturation. Behav. Biol. 8:1973;557-596.
8. Amaral D.G., Witter M.P. The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience. 31:1989;571-591.
9. Amaral, D.G., Witter, M.P., 1995. Hippocampal formation. In: Paxinos, G. (Ed.), The Rat Nervous System. Academic Press, San Diego, pp. 443-493.
10. Anagnostaras S.G., Maren S., Fanselow M.S. Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. J. Neurosci. 19:1999;1106-1114.
11. Anagnostaras S.G., Gale G.D., Fanselow M.S. Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus. 11:2001;8-17.
12. Anagnostaras S.G., Gale G.D., Fanselow M.S. The hippocampus and Pavlovian fear conditioning: reply to Bast et al. Hippocampus. 12:2002;561-565.
13. Anthony B.J., Graham F.K. Evidence for sensory-selective set in young infants. Science. 220:1983;742-744.
14. Bär P.R., Gispen W.H., Isaacson R.L. Behavioral and regional neurochemical sequelae of hippocampal destruction in the rat. Pharmacol. Biochem. Behav. 14:1981;305-312.
15. Bakshi V.P., Geyer M.A. Multiple limbic regions mediate the disruption in prepulse inhibition produced in rats by the non-competitive NMDA antagonist dizocilpine. J. Neurosci. 18:1998;8394-8401.
16. Bakshi V.P., Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor-gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience. 92:1999;113-121.
17. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor-gating of the startle response. J. Pharmacol. Exp. Ther. 271:1994;787-794.
18. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., Iversen S.D., Rawlins J.N.P. Double dissociation of function within the hippocampus: a comparsion of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav. Neurosci. 113:1999;1170-1188.
19. Bannerman D.M., Gilmour G., Norman G., Lemaire M., Iversen S.D., Rawlins J.N.P. The time course of the hyperactivity that follows lesions or temporary inactivation of the fimbria fornix. Behav. Brain Res. 120:2001;1-11.
20. Bannerman D.M., Deacon R.J., Offen S., Friswell J., Grubb M., Rawlins J.N.P. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav. Neurosci. 116:2002;884-901.
21. Bannerman D.M., Grubb M., Deacon R.M.J., Yee B.K., Feldon J., Rawlins J.N.P. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res. 139:2003;197-213.
22. Bardgett M.E., Henry J.D. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience. 94:1999;59-70.
23. Bardgett M.E., Jackson J.L., Taylor G.T., Csernansky J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behav. Brain Res. 70:1995;153-164.
24. Barr W.B. Schizophrenia and attention deficit disorder: two complex disorders of attention. Ann. N.Y. Sci. 31:2001;239-250.
25. Bast, T., 2002. Behavioral functions of the rat ventral and dorsal hippocampus: effects of local pharmacological manipulations on sensorimotor and memory processes. Ph.D. thesis, The Swiss Federal Institute of Technology Zurich (ETH Zürich), No. 14868 ( http://e-collection.ethbib.ethz.ch/show?type=diss&nr=14868 ).
26. Bast T., Zhang W., Feldon J., White I.M. Effects of MK-801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats. Pharmacol. Biochem. Behav. 67:2000;647-658.
27. Bast T., Zhang W.-N., Feldon J. Effects of the atypical neuroleptic clozapine in the prepulse inhibition paradigm (abstract). Behav. Pharmacol. 12(Suppl. 1):2001a;S5.
28. Bast T., Zhang W.-N., Feldon J. Hippocampus and classical fear conditioning. Hippocampus. 11:2001b;828-831.
29. A receptor antagonist picrotoxin. Psychopharmacology. 156:2001c;225-233.
30. A agonist muscimol. Exp. Brain Res. 139:2001d;39-52.
31. Bast T., Zhang W.-N., Heidbreder C., Feldon J. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience. 103:2001e;325-335.
32. Bast T., Pezze M.A., Feldon J. Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition. Behav. Pharmacol. 13:2002;669-673.
33. Bast T., Zhang W.-N., Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: the effects of local NMDA-receptor blockade and stimulation. Hippocampus. 13:2003;657-675.
34. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:1983;173-196.
35. Beninger R.J., Musgrave M.A., Dickson P.R. Unilateral injections of a D2 but not D1 agonist into the frontal cortex of rats produce contralateral directional bias. Pharmacol. Biochem. Behav. 37:1990;387-392.
36. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Rev. 31:2000;251-269.
37. Berke J.D., Eichenbaum H.B. Drug addiction and the hippocampus. Science. 294:2001;123.
38. Blaha C.D., Yang C.R., Floresco S.B., Barr A., Phillips A.G. Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens. Eur. J. Neurosci. 9:1997;902-911.
39. Blanchard D.C., Blanchard R.J., Lee E.M.C., Fukunaga K.K. Movement arrest and the hippocampus. Physiol. Psychol. 5:1977;331-335.
40. Bland B.H., Oddie S.D. Theta band oscillation and synchrony in the hippocampal formation and associated structures: the case for its role in sensorimotor integration. Behav. Brain Res. 127:2001;119-136.
41. Braff D.L., Geyer M.A. Sensorimotor-gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry. 47:1990;181-188.
42. Braff D.L., Grillion C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215.
43. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156:2001;234-258.
44. Brenner D.M., Bardgett M.E. Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation. Pharmacol. Biochem. Behav. 60:1998;759-764.
45. Brudzynski S.M., Gibson C.J. Release of dopamine in the nucleus accumbens caused by stimulation of the subiculum in freely moving rats. Brain Res. Bull. 42:1997;303-308.
46. Buhl E.H., Halasy K., Somogyi P. Diverse sources of hippocampal unitary inhibitory post-synaptic potentials and the number of synaptic release sites. Nature. 368:1994;823-828.
47. Bures J., Fenton A.A. Neurophysiology of spatial cognition. News Physiol. Sci. 15:2000;233-240.
48. Busatto G.F., Pilowsky L.S., Costa D.C., Ell P.J., David A.S., Lucey J.V., Kerwin R.W. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am. J. Psychiatry. 154:1995;56-63.
49. Bushnell P.J. Behavioral approaches to the assessment of attention in animals. Psychopharmacology. 138:1998;231-259.
50. Cahill L., McGaugh J.L., Weinberger N.M. The neurobiology of learning and memory: some reminders to remember. Trends Neurosci. 24:2001;578-581.
51. Caine S.B., Geyer M.A., Swerdlow N.R. Carbachol infusion into the dentate gyrus disrupts senorimotor gating of startle in the rat. Psychopharmacology. 105:1991;347-354.
52. Caine S.B., Geyer M.A., Swerdlow N.R. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol. Biochem. Behav. 43:1992;1201-1208.
53. Caine S.B., Humby T., Robbins T.W., Everitt B.J. Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotor activity, cocaine self-administration, and prepulse inhibition of startle. Behav. Neurosci. 115:2001;880-894.
54. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41:2001;237-260.
55. Carr D.B., Sesack S.R. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J. Comp. Neurol. 369:1996;1-15.
56. Cassel J.-C., Cassel S., Galani R., Kelche C., Will B., Jarrard L. Fimbria-fornix vs. selective hippocampal lesions in rats: effects on locomotor activity and spatial learning and memory. Neurobiol. Learn. Mem. 69:1998;22-45.
57. Chan K.-H., Morell J.R., Jarrard L.E., Davidson T.L. Reconsideration of the role of the hippocampus in learned inhibition. Behav. Brain Res. 119:2001;111-130.
58. Collingridge G.L., Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40:1989;143-210.
59. Coover G.D., Levine S. Auditory startle response of hippocampectomized rats. Physiol. Behav. 9:1972;75-77.
60. Corcoran K.A., Maren S. Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. J. Neurosci. 21:2001;1720-1726.
61. Coutureau E., Galani R., Jarrard L.E., Cassel J.-C. Selective lesions of the entorhinal cortex, the hippocampus, or the fimbria-fornix in rats: a comparison of effects on spontaneous and amphetamine-induced locomotion. Exp. Brain Res. 131:2000;381-392.
62. A receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2:1999;833-839.
63. Csernansky J.G., Joshi S., Wang L., Haller J.W., Gado M., Miller J.P., Grenander U., Miller M.I. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11406-11411.
64. Daenen E.W.P.M., Wolterink G., Van Der Heyden J.A., Kruse C.G., Van Ree J.M. Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. Eur. Neuropsychopharmacol. 13:2003;187-197.
65. Davis M., Gendelman D.S., Tischler M.D., Gendelman P.M. A primary acoustic startle circuit: lesion and stimulation studies. J. Neurosci. 2:1982;781-805.
66. Davis M., Walker D.L., Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Phil. Trans. R. Soc. Lond. B. 352:1997;1675-1687.
67. Deacon R.J., Bannerman D.M., Rawlins J.N.P. Anxiolytic effects of cytotoxic hippocampal lesions in rats. Behav. Neurosci. 116:2002;494-497.
68. De Hoz L., Knox J., Morris R.G. The longitudinal axis of the hippocampus: both septal and temporal poles of the hippocampus support watermaze spatial learning depending on the training protocol. Hippocampus. 13:2003;587-603.
69. Douglas R.J. The hippocampus and behavior. Psychol. Bull. 67:1967;416-442.
70. Eichenbaum H. A cortical-hippocampal system for declarative memory. Nat. Rev. Neurosci. 1:2000;41-50.
71. Ellenbroek B.A., Lubbers L.J., Cools A.R. The role of hippocampal dopamine receptors in prepulse inhibition. Eur. J. Neurosci. 15:2002;1237-1243.
72. Fanselow M.S. Contextual fear, gestalt memories, and the hippocampus. Behav. Brain Res. 110:2000;73-81.
73. Feldon J., Weiner I. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J. Psychiatry Res. 26:1992;345-366.
74. Fendt M., Li L., Yeomans J.S. Brain-stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology. 156:2001;216-224.
75. Fenton A.A., Arolfo M.P., Nerad L., Bures J. Interhippocampal synthesis of lateralized place navigation engrams. Hippocampus. 5:1995;16-24.
76. Ferbinteanu J., McDonald R.J. Dorsal and ventral hippocampus: same or different? Psychobiology. 28:2000;314-324.
77. Ferbinteanu J., Ray C., McDonald R.J. Both dorsal and ventral hippocampus contribute to spatial learning in Long-Evans rats. Neurosci. Lett. 345:2003;131-135.
78. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66:2000;65-72.
79. Finamore T.L., Seybold K.S., Noble M., Port R.L. Contributions of hippocampal cellular damage and NMDA receptor dysfunction to behavioral markers of schizophrenia. Intern. J. Neurosci. 109:2001;61-70.
80. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. II. Muscarinic locomotor activation. Brain Res. Rev. 4:1982a;105-127.
81. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. III. Licocaine versus picrotoxin. Brain Res. Rev. 4:1982b;129-136.
82. Flicker C., Geyer M.A. The hippocampus as a possible site of action for increased locomotion during intracerebral infusions of norepinephrine. Behav. Neural Biol. 34:1982c;421-426.
83. Floresco S.B., Seamans J.K., Phillips A.G. Differential effects of lidocaine infusion into the ventral CA1/subiculum or the nucleus accumbens on the acquisition and retention of spatial information. Behav. Brain Res. 81:1996;163-171.
84. Floresco S.B., Seamans J.K., Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J. Neurosci. 17:1997;1880-1890.
85. Floresco S.B., Todd C.L., Grace A.A. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of the ventral tegmental area dopamine neurons. J. Neurosci. 21:2001;4915-4922.
86. Gasbarri A., Sulli A., Packard M.G. The dopaminergic mesencephalic projection to the hippocampal formation in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry. 21:1997;1-22.
87. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor-gating and habituation deficits in schizophrenia. Brain Res. Bull. 25:1990;485-498.
88. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor-gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156:2001;117-154.
89. Giménez-Llort L., Wang F.-H., Ögren S.O., Ferré S. Local dopaminergic modulation of the motor activity induced by N-methyl-D-aspartate receptor stimulation in the ventral hippocampus. Neuropsychopharmacology. 26:2002;737-743.
90. Gothelf D., Soreni N., Nachman R.P., Tyano S., Hiss Y., Reiner O., Weizman A. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia. Eur. Neuropsychopharmacol. 10:2000;389-395.
91. Grace A.A. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res. Rev. 31:2000;330-341.
92. Graham F.K. The more or less startling effects of weak prestimulation. Pychophysiology. 12:1975;238-248.
93. Gray J.A. Précis of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Behav. Brain Sci. 5:1982;469-534.
94. Gray, J.A., 1995. A model of the limbic system and basal ganglia: application to anxiety and schizophrenia. In: Gazzaniga, M.S. (Ed.), The Cognitive Neurosciences. MIT Press, Cambridge, MA, pp. 1165-1176.
95. Gray J.A. Integrating schizophrenia. Schizophr. Bull. 24:1998;249-266.
96. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., Smith A.D. The neuropsychology of schizophrenia. Behav. Brain Sci. 14:1991;1-84.
97. Gray J.A., Kumari V., Lawrence N., Young A.M.J. Functions of the dopaminergic innervation of the nucleus accumbens. Psychobiology. 27:1999;225-235.
98. Gray J.A., McNaughton N. Comparison between the behavioural effects of septal and hippocampal lesions: a review. Neurosci. Biobehav. Rev. 7:1983;119-188.
99. Groenewegen H.J., Vermeulen-Van der Zee E., Te Kortschot A., Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat: a study using anterograde transport of Phaseolus vulgaris-leucoagglutinin. Neuroscience. 23:1987;103-120.
100. Grunze H.C.R., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16:1996;2034-2043.
101. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 20RC106:2000;1-5.
102. Halim N.D., Swerdlow N.R. Distributed neurodegenerative changes 2-28 days after ventral hippocampal excitotoxic lesions in rats. Brain Res. 873:2000;60-74.
103. Hallak M., Irtenkauf S.M., Janusz C.A., Cotton D.B. Stimulation and inhibition of N-methyl-D-aspartate receptors in rats: developing a seizure model. Am. J. Obstet. Gynecol. 169:1993;695-700.
104. Hamm A.O., Weike A.I., Schupp H.T. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology. 156:2001;259-265.
105. Harrison P.J. The neuropathology of schizophrenia. A critical review of data and their interpretation. Brain. 122:1999;593-624.
106. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 11:2001;508-519.
107. Hart S., Zreik M., Carper R., Swerdlow N.R. Localizing haloperidol effects on sensorimotor-gating in a predictive model of antipsychotic potency. Pharmacol. Biochem. Behav. 61:1998;113-119.
108. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Singer M.B., Germans M.K., Schnur D.B., Jimenez E.A., Buchsbaum B.R., Troyer B.T. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology. 35:1998;186-198.
109. Hazlett E.A., Buchsbaum M.S., Tang C.Y., Fleischman M.B., Wei T.-C., Byne W., Haznedar M.M. Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study. Biol. Psychiatry. 50:2001;281-291.
110. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus. 11:2001;520-528.
111. Heckers S., Konradi C. Hippocampal neurons in schizophrenia. J. Neural Transm. 109:2002;891-905.
112. Hoffman D.C., Donovan H., Cassela J.V. The effects of haloperidol and clozapine on the disruption of sensorimotor-gating induced by the non-competitive glutamate antagonist MK-801. Psychopharmacology. 111:1993;437-442.
113. Holstege G. Descending motor pathways and the spinal motor system: limbic and non-limbic components. Prog. Brain Res. 87:1991;307-421.
114. Hutchison K.E., McGeary J., Wooden A., Blumenthal T., Ito T. Startle magnitude and prepulse inhibition: effects of alcohol and attention. Psychopharmacology. 167:2003;235-241.
115. Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine D1/D2 agonists. Neuroscience. 113:2002;939-955.
116. Isaacson R.L. Hippocampal damage: effects on dopaminergic systems of the basal ganglia. Int. Rev. Neurobiol. 25:1984;339-359.
117. Jarrard L.E. Retrograde amnesia and consolidation: anatomical and lesion considerations. Hippocampus. 11:2001;43-49.
118. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol. 313:1991;574-586.
119. Jay T.M., Thierry A.-M., Wiklund L., Glowinski J. Excitatory amino acid pathway from the hippocampus to the prefrontal cortex. Contribution of AMPA receptors in hippocampo-prefrontal cortex transmission. Eur. J. Neurosci. 4:1992;1285-1295.
120. Kang E., Gabriel M. Hippocampal modulation of cingulo-thalamic neuronal activity and discriminative avoidance learning in rats. Hippocampus. 8:1998;491-510.
121. Kawabe K., Ichitani Y., Iwasaki T. Effects of intrahippocampal AP5 treatment on raidal-arm maze performance in rats. Brain Res. 781:1998;300-306.
122. Kelley A.E., Domesick V.B. The distribution of the projections from the hippocampal formation to the nucleus accumbens in the rat: an anterograde-retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
123. Kemble E.D., Ison J.R. Limbic lesions and the inhibition of startle reactions in the rat by conditions of preliminary stimulation. Physiol. Behav. 7:1971;925-928.
124. Kimble D.P. Possible inhibitory functions of the hippocampus. Neuropsychologia. 7:1969;235-244.
125. Kinon B.J., Lieberman J.A. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology. 124:1996;2-34.
126. Kjelstrup K.G., Tuvnes G.A., Steffenach H.-A., Murison R., Moser E.I., Moser M.-B. Reduced fear expression after lesions of the ventral hippocampus. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10825-10830.
127. Klarner A., Koch M., Schnitzler H.U. Induction of Fos-protein in the forebrain and disruption of sensorimotor-gating following N-methyl-D-aspartate infusion into the ventral hippocampus. Neuroscience. 84:1998;443-452.
128. Knight R. Contribution of human hippocampal region to novelty detection. Nature. 383:1996;256-259.
129. Koch M. The neurobiology of startle. Prog. Neurobiol. 59:1999;107-128.
130. Koch M., Klarner A., Schnitzler H.U. Lesions of the rat piriform cortex prevent long-lasting sensorimotor-gating deficits induced by stimulation of the ventral hippocampus. Neurosci. Lett. 275:1999;195-198.
131. Kumari V., Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology. 162:2002;97-101.
132. Kumari V., Gray J.A., Geyer M.A., ffytche D., Soni W., Mitterschiffthaler M.T., Vythelingum G.N., Simmons A., Williams S.C.R., Sharma T. Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res. 122:2003;99-113.
133. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 82:1998;431-442.
134. Lacroix L., Broersen L.M., Feldon J., Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav. Brain Res. 107:2000;111-121.
135. Lang P.J. The emotion probe. Studies of motivation and attention. Am. Psychol. 50:1995;372-385.
136. Leaton R.N. Habituation of startle response, lick suppression, and exploratory behavior in rats with hippocampal lesions. J. Comp. Physiol. Psychol. 95:1981;813-826.
137. Lee Y., Davis M. Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17:1997a;6424-6433.
138. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17:1997b;6434-6446.
139. Lee I., Kesner R.P. Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory. Nat. Neurosci. 5:2002;162-168.
140. Legault M., Wise R.A. Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and the nucleus accumbens. Synapse. 31:1999;241-249.
141. Legault M., Rompré P.-P., Wise R.A. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J. Neurosci. 20:2000;1635-1642.
142. LeMoal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
143. Le Pen G., Moreau J.-L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not haloperidol. Neuropsychopharmacology. 27:2002;1-11.
144. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., Moreau J.-L. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evalauation of an animal model of schizophrenia. Behav. Pharmacol. 11:2000;257-268.
145. Lewis D.A., Lieberman J.A. Catching up on schiziphrenia: natural history and neurobiology. Neuron. 28:2000;325-334.
146. Liddle P.F., Friston K.J., Frith C.D., Jones T., Hirsch S.R., Fackowiack R.S.J. Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry. 160:1992;179-186.
147. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 23:2000;223-239.
148. Lipska B.K., Jaskiw G.E., Karoum F., Phillips I., Kleinman J.E., Weinberger D.R. Dorsal hippocampal lesions do not affect dopaminergic indices in the basal ganglia. Pharmacol. Biochem. Behav. 40:1991;181-184.
149. Lipska B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1992;1-6.
150. Lipska B.K., Jaskiw G.E., Braun A.R., Weinberger D.R. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypcic behaviors in the rat. Biol. Psychiatry. 38:1995a;255-262.
151. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995b;35-43.
152. Lisman J.E., Otmakhova N.A. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine. Hippocampus. 11:2001;551-568.
153. Lomber S.G. The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J. Neurosci. Meth. 86:1999;109-117.
154. Löw K., Crestani F., Keist R., Benke D., Brünig I., Benson J., Fritschy J.M., Rülicke T., Bluethmann H., Möhler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 290:2000;131-134.
155. Ludewig K., Geyer M.A., Etzensberger M., Vollenweider F.X. Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr. Res. 55:2002;129-137.
156. A-benzodiazepine receptor binding in panic disorder. Arch. Gen. Psychiatry. 55:1998;715-720.
157. Martin J.H., Ghez C. Pharmacological inactivation in the analysis of the central control of movement. J. Neurosci. Meth. 86:1999;145-159.
158. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br. J. Psychiatry. 34:1961;103-117.
159. Mitchell S.N., Yee B.K., Feldon J., Gray J.A., Rawlins J.N.P. Activation of the retrohippocampal region in the rat causes dopamine release in the nucleus accumbens: disruption by fornix transsection. Eur. J. Pharmacol. 407:2000;131-138.
160. Mittleman G., LeDuc P., Wishaw I.Q. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia. Behav. Brain Res. 55:1993;253-267.
161. Mogenson G.J., Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav. Neural Biol. 42:1984;38-51.
162. Mogenson, G.J., Yang, C.R., 1991. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. In: Napier, T.C., Kalivas, P.W., Hanin, I. (Eds.), The Basal Forebrain. Plenum Press, New York, pp. 267-290.
163. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 59:1980;107-128.
164. Morris R.G.M., Frey U. Hippocampal synaptic plascticity: role in spatial learning or the automatic recording of attended experience? Phil. Trans. R. Soc. Lond. B. 352:1997;1489-1503.
165. Morris R.G., Halliwell R.F., Bowery N. Synaptic plasticity and learning II: do different kinds of plasticity underlie different kinds of learning? Neuropsychologia. 27:1989;41-59.
166. Morris R.G.M., Moser E.I., Riedel G., Martin S.J., Sandin J., Day M., O'Carroll C. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Phil. Trans. R. Soc. Lond. B. 358:2003;773-786.
167. Moser M.-B., Moser E.I. Distributed encoding and retrieval of spatial memory in the hippocampus. J. Neurosci. 18:1998a;7535-7542.
168. Moser M.-B., Moser E.I. Functional differentiation in the hippocampus. Hippocampus. 8:1998b;608-619.
169. Moser E.I., Moser M.-B., Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J. Neurosci. 13:1993;3916-3925.
170. Moser M.-B., Moser E.I., Forrest E., Andersen P., Morris R.G. Spatial learning with a minislab in the dorsal hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9697-9701.
171. Moser P.C., Hitchcock J.M., Lister S., Moran P.M. The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res. Rev. 33:2000;275-307.
172. Moss S., Sharott A., Goodhead L.H., Mitchell S.N. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 460:2003;117-125.
173. Myers R.D. Injection of solutions into cerebral tissue: relation between volume and diffusion. Physiol. Behav. 1:1966;171-174.
174. 3H -norepinephrine into the hypothalamus of the rat: diffusions into tissue and ventricles Physiol. Behav. 7:1971;743-751.
175. Nazar M., Siemiatkowski M., Clonkowska A., Sienkiewicz-Jarosz H., Plaznik A. The role of the hippocampus and 5-HT/GABA interactions in the central effects of benzodiazepine receptor ligands. J. Neural Transm. 106:1999;369-381.
176. Norris C.M., Blumenthal T.D. A relationship between inhibition of the acoustic startle response and the protection of prepulse processing. Psychobiology. 24:1996;160-168.
177. O'Keefe J., Nadel L. Précis of O'Keefe and Nadel's The hippocampus as a cognitive map. Behav. Brain Sci. 2:1979;487-533.
178. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatry Res. 33:1999;523-533.
179. Olton D.S., Becker J.T., Handelmann G.E. Hippocampus, space, and memory. Behav. Brain Sci. 2:1979;313-365.
180. Ottersen O.P., Storm-Mathisen J. Different neuronal localization of aspartate-like and glutamate-like immunoreactivitties in the hippocampus of rat, guinea-pig and Senegalese baboon (Papio papio), with a note on the distribution of γ-aminobutyrate. Neuroscience. 16:1985;589-606.
181. Ouagazzal A.-M., Creese I. Intra-accumbens infusion of D3 receptor agonists reduces spontaneous and dopamine-induced locomotion. Pharmacol. Biochem. Behav. 67:2000;637-645.
182. Packard M.G., McGaugh J.L. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol. Learn. Mem. 65:1996;65-72.
183. Papez J.W. A proposed mechanism of emotion. Arch. Neurol. Psychiatry. 38:1937;725-743.
184. Paxinos, G., Watson, C., 1998. The Rat Brain In Sterotaxic Coordinates. Academic Press, San Diego.
185. Peleg, D., Pezze, M.A., Ferger, B., Murphy, C.A., Feldon, J., Bast, T., 2003. Effect of ventral hippocampal NMDA stimulation on dopamine transmission in medial prefrontral cortex: in vivo microdialysis study in freely moving rats. In: Kehr, J., Fuxe, K., Ungerstedt, U., Svensson, T.H. (Eds.), Monitoring Molecules in Neuroscience. Proceedings of the 10th International Conference on In Vivo Methods. Karolinska University Press, Stockholm, pp 332-334.
186. Pezze M., Bast T., Feldon J. Effects of dopamine receptor stimulation or blockade on locomotor activity, sensorimotor-gating, and conditioned fear. Behav. Pharmacol. S77(12 (Suppl. 1)):2001;S77.
187. Pezze M., Bast T., Feldon J. Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb. Cortex. 13:2003;371-380.
188. Pitkänen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex. Ann. N.Y. Acad. Sci. 911:2000;369-391.
189. Pouzet B., Feldon J., Veenman C.L., Yee B.K., Richmond M., Rawlins J.N.P., Weiner I. The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. Behav. Neurosci. 113:1999;968-981.
190. Pralong E., Magistretti P., Stoop R. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for psychiatric disorders. Prog. Neurobiol. 67:2002;173-202.
191. Rawlins J.N.P. Associations across time: the hippocampus as a temporary memory store. Behav. Brain Sci. 8:1985;479-496.
192. Richmond M.A., Yee B.K., Pouzet B., Veenman L., Rawlins J.N.P., Feldon J., Bannerman D.M. Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic lesions on conditioned freezing. Behav. Neurosci. 113:1999;1189-1203.
193. Riedel G., Micheau J., Lam A.G.M., Roloff E.v.L., Martin S.J., Bridge H., de Hoz L., Poeschel B., McCulloch J., Morris R.G.M. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat. Neurosci. 2:1999;898-905.
194. Robbins, T.W., Muir, J.R., Killcross, A.S., Pretsell, D.O., 1993. Methods for assessing attention and stimulus control in the rat. In: Sahgal, A. (Ed.), Behavioral Neuroscience: A Practical Approach, vol. 1. Oxford University Press, New York, pp. 13-47.
195. Rodgers R.J. Animal models of anxiety: where next? Behav. Pharmacol. 8:1997;477-496.
196. Routtenberg A. Intracranial chemical injection and behavior: a critical review. Behav. Biol. 7:1972;601-641.
197. Rudy J.W., Sutherland R.J. Configural association theory and the hippocampal formation: an appraisal and reconfiguration. Hippocampus. 5:1995;375-389.
198. Sandkühler J., Maisch B., Zimmermann M. The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp. Brain Res. 68:1987;168-178.
199. Schmajuk N.A. Psychological theories of hippocampal function. Physiol. Psychol. 12:1984;166-183.
200. Schoenfeld T.A., Hamilton L.W. Secondary brain changes following lesions: a new paradigm for lesion experimentation. Physiol. Behav. 18:1977;951-967.
201. Seeman P., Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U.S.A. 97:2000;7673-7675.
202. Sesack S.R., Pickel V.M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-279.
203. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
204. Smialowski A., Maj J. Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats. Psychopharmacology. 86:1985;468-471.
205. Sokoloff P., Giros B., Martres M.-P., Bouthenet M.-L., Schwartz J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1991;146-151.
206. Steele R.J., Morris R.G.M. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus. 9:1999;118-136.
207. 1A receptor agonists. Neuropharmacology. 32:1993a;977-985.
208. 3 receptor antagonists. Neuropharmacology. 32:1993b;987-993.
209. Stein D.G. The ghost in the machine is still there. Behav. Brain Sci. 2:1979;346-348.
210. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J. Comp. Neurol. 172:1977;49-84.
211. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenic-like sensorimotor-gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101:1990;414-420.
212. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor-gating disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
213. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of sensorimotor-gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 11:2000a;185-204.
214. Swerdlow N.R., Taaid N., Halim N., Randolph E., Kim Y.K., Auerbach P. Hippocampal lesions enhance startle-gating disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience. 96:2000b;523-536.
215. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001a;194-215.
216. Swerdlow N.R., Hanlon F.M., Hennig L., Kim Y.K., Gaude I., Halim N.D. Regulation of sensorimotor-gating in rats by hippocampal NMDA: anatomical localization. Brain Res. 898:2001b;195-203.
217. Szeszko P.R., Strous R.D., Goldman R.S., Ashtari M., Knuth K.H., Lieberman J.A., Bilder R.M. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am. J. Psychiatry. 159:2002;217-226.
218. Taepavarapruk P., Floresco S.B., Phillips A.G. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology. 151:2000;242-251.
219. Takahaschi H., Takada Y., Nagai N., Urano T., Takada A. Serotonergic neurons projecting to hippocampus activate locomotion. Brain Res. 869:2000;194-202.
220. 2C receptors. Neurosci. Res. 40:2001;97-103.
221. 4 receptors in the hippocampus modulate rat locomotor activity. Hippocampus. 12:2002;304-310.
222. Tuvnes F.A., Steffenach H.-A., Murison R., Moser M.-B., Moser E.I. Selective hippocampal lesions do not increase adrenocortical activity. J. Neurosci. 23:2003;4345-4354.
223. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol. 63:2001;241-320.
224. Usada I., Tanaka K., Chiba T. Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextrane amine study. Brain Res. 797:1998;73-93.
225. Vanderwolf C.H., Caine D.P. The behavioral neurobiology of learning and memory: a conceptual reorientation. Brain Res. Rev. 19:1994;264-297.
226. Varty G.B., Higgins G.A. Examination of drug-induced and isolation-induces disruptions of prepulse inhitbition as models to screen antpsychotic drugs. Pschopharmacolgoy. 122:1995;15-26.
227. Velakoulis D., Stuart G.W., Wood S.J., Smith D.J., Brewer W.J., Desmond P., Singh B., Copolov D., Pantelis C. Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol. Psychiatry. 50:2001;531-539.
228. Verwer R.W.H., Meijer R.J., Van Uum H.F.M., Witter M.P. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus. 7:1997;397-402.
229. Vinogradova O.S. Hippocampus as comparator: role of the two input and output systems of the hippocampus in selection and registration of information. Hippocampus. 11:2001;578-598.
230. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience. 5:1980;1691-1698.
231. Wan F.-J., Swerdlow N.R. Sensorimotor-gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res. 722:1996;168-176.
232. Wan F.-.J., Caine S.B., Swerdlow N.R. The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. Eur. J. Pharmacol. 314:1996;9-18.
233. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 45:1999;395-402.
234. Wiley J.L. Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response. Pharmacol. Biochem. Behav. 49:1994;1025-1028.
235. Wilkinson L.S., Mittleman G., Torres E., Humby T., Hall F.S., Robbins T.W. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav. Brain Res. 55:1993;143-150.
236. Witter, M.P., 1986. A survey of the anatomy of the hippocampal formation, with emphasis on the septotemporal organization of its intrinsic and extrinsic connections. In: Schwarcz, R., Ben-Ari, Y. (Eds.), Advances in Experimental and Medical Biology: Excitatory Amino Acids and Epilepsy, vol. 203. Plenum Press, New York, pp. 67-82.
237. Wu M., Brudzynski S.M. Mesolibmic dopamine terminals and locomotor activity induced from the subiculum. NeuroReport. 6:1995;1601-1604.
238. 2+. Hippocampus. 10:2000;57-63.
239. Yang C.R., Mogenson G.J. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioral study. Neuroscience. 23:1987;1041-1055.
240. Yeomans J.S., Frankland P.W. The acoustic startle reflex: neurons and connections. Brain Res. Rev. 21:1996;301-314.
241. Young S.L., Bohenek D.L., Fanselow M.S. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. Behav. Neurosci. 108:1994;19-29.
242. Zhang W.-N., Pouzet B., Jongen-Rêlo A.L., Weiner I., Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not haloperidol: a possible model for the screening of atypical antipsychotics. NeuroReport. 10:1999;2533-2538.
243. Zhang W.-N., Bast T., Feldon J. Microinfusion of the non-competitive N-methyl-D-aspartate antagonist MK-801 (dizocilpine) into the dorsal hippocampus of Wistar rats does not affect latent inhibition and prepulse inhibition but increases startle reaction and locomotor activity. Neuroscience. 101:2000;589-599.
244. Zhang W.-N., Bast T., Feldon J. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-D-aspartate or its non-competitive antagonist MK-801 into the ventral hippocampus. Behav. Brain Res. 126:2001;159-174.
245. Zhang W.-N., Bast T., Feldon J. Effects of hippocampal N-methyl-D-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav. Neurosci. 116:2002a;72-84.
246. Zhang W.-N., Bast T., Feldon J. Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus. Pharmacol. Biochem. Behav. 73:2002b;929-940.
247. Zhuravin I.A., Bures J. Extent of the tetrodotoxin induced blockade examined by pupillary paralysis elicited by intracerebral injection of the drug. Exp. Brain Res. 83:1991;687-690.